Literature DB >> 36010660

Single Cell Analysis of Cultivated Fibroblasts from Chronic Pancreatitis and Pancreatic Cancer Patients.

Yoshiaki Sunami1, Yijun Chen1, Bogusz Trojanowicz1, Matthias Sommerer1, Monika Hämmerle2, Roland Eils3,4, Jörg Kleeff1.   

Abstract

Cancer-associated fibroblasts (CAFs) play a major role in the progression and drug resistance of pancreatic cancer. Recent studies suggest that CAFs exhibit functional heterogeneity and distinct transcriptomic signatures in pancreatic cancer. Pancreatic fibroblasts also form an integral component in pancreatic diseases such as chronic pancreatitis named disease-associated fibroblasts (DAFs). However, intra-tumoral heterogeneity of CAFs in pancreatic cancer patients and their pivotal role in cancer-related mechanisms have not been fully elucidated. Further, it has not been elucidated whether CAF subtypes identified in pancreatic cancer also exist in chronic pancreatitis. In this study, we used primary isolated fibroblasts from pancreatic cancer and chronic pancreatitis patients using the outgrowth method. Single-cell RNA sequencing (scRNA-seq) was performed, and bioinformatics analysis identified highly variable genes, including factors associated with overall survival of pancreatic cancer patients. The majority of highly variable genes are involved in the cell cycle. Instead of previously classified myofibroblastic (myCAFs), inflammatory (iCAFs), and antigen-presenting (ap) CAFs, we identified a myCAFs-like subtype in all cases. Most interestingly, after cell cycle regression, we observed 135 highly variable genes commonly identified in chronic pancreatitis and pancreatic cancer patients. This study is the first to conduct scRNAseq and bioinformatics analyses to compare CAFs/DAFs from both chronic pancreatitis and pancreatic cancer patients. Further studies are required to select and identify stromal factors in DAFs from chronic pancreatitis cases, which are commonly expressed also in CAFs potentially contributing to pancreatic cancer development.

Entities:  

Keywords:  cancer-associated fibroblasts; cellular plasticity; chronic pancreatitis; pancreatic cancer; single-cell RNA sequencing

Mesh:

Year:  2022        PMID: 36010660      PMCID: PMC9406708          DOI: 10.3390/cells11162583

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   7.666


1. Introduction

Pancreatic cancer is currently the fourth leading cause of cancer deaths and is projected to become the second most common cancer death in the United States by 2030 [1,2]. The dense stromal tumor microenvironment, which accounts for up to ~90% of the pancreatic tumor mass, is a major cause of resistance to chemotherapy and radiotherapy [3,4,5]. The major stromal compartment consists of CAFs, which are a source of extracellular matrix proteins and potential therapeutic targets [6]. Fibrotic stroma and generally termed disease-associated fibroblasts (DAFs) form an integral component in pancreatic diseases including pancreatic cancer (CAFs) and chronic pancreatitis [7]. CAF depletion can also have tumor-promoting effects, suggesting that CAFs exhibit distinct functional heterogeneity [5]. CAFs, which are derived from several cell types such as pancreatic stellate cells or mesenchymal stem cells, play a major role in the progression and drug resistance of pancreatic cancer [8,9]. Recent studies suggest that CAF subtypes exhibit distinct transcriptomic signatures in pancreatic cancer. Previous human and murine studies described several CAF subtypes such as myofibroblastic CAFs (myCAFs) expressing Acta2, (coding α-smooth muscle actin), Vim (vimentin), and Ctgf (connective tissue growth factor), Col1a1, Col5a1, and Col6a1, inflammatory CAFs (iCAFs) expressing Il1, Il6, Il11, and Lif (Leukemia inhibitory factor) [10], as well as antigen-presenting CAFs (apCAFs) expressing Slpi, Saa3, Cd74, H2-Ab1, Nkain4 (Sodium/Potassium Transporting ATPase Interacting 4), and Irf5 [11]. MyCAFs are associated with an extracellular matrix signature, while iCAFs are suggested to establish an immunosuppressive microenvironment [9]. ApCAFs may play an immunomodulatory role in pancreatic cancer [9]. In the current study, we used CAFs/DAFs isolated from pancreatic cancer and chronic pancreatitis patients via the outgrowth method to evaluate the presence of myCAF, iCAF, or apCAF subtypes in these specimens, and for further stratification of fibroblast subtypes associated with pancreatic disease development and progression.

2. Materials and Methods

2.1. Human Subjects

Human pancreas samples from patients with pancreatic cancer or chronic pancreatitis were obtained from the Department of Surgery, University Medical Center Halle, Martin-Luther-University Halle-Wittenberg, Germany. The study on human material was approved by the institutional review board of the Medical Faculty of the Martin-Luther-University Halle-Wittenberg and designated in accordance with the Declaration of Helsinki (Approval number: 2019-037). Written informed consent was obtained from all patients.

2.2. Isolation and Cultivation of Fibroblasts

CAFs/DAFs from patient specimens were obtained by the outgrowth method, which has been described previously with modifications [12]. Briefly, pancreatic tissue was cut into ca. 20 mm3 pieces, seeded in a plate in the presence of Dulbecco’s Modified Eagle’s Medium (DMEM) low glucose and F12, supplemented with 16% fetal bovine serum, 1% penicillin-streptomycin, and 1% amphotericin, and maintained at 37 °C, 5% CO2 until fibroblasts grew out. Single-cell RNA sequencing (10X Genomics, Pleasanton, CA, USA) was performed with cells in passage-3.

2.3. Single-Cell RNA Sequencing and Bioinformatics Analysis

Isolated CAFs/DAFs were processed with the 10X Genomics Single Cell 3’ v3 Reagent Kit [13]. Samples were processed according to the manufacturer’s user guide (10X Genomics). Final libraries were sequenced with the NextSeq 500 system (Illumina, San Diego, CA, USA) in high-output mode (paired end, 75 base pairs). Single-cell RNA sequencing and bioinformatics analyses were performed with cellranger 6.0.0. Gene expression was quantified using the default 10X Cell Ranger v3 pipeline using the GRCh37/hg19 Reference provided by 10X Genomics. UMI and genes were filtered for each sample and, in general, cells with a minimum number of 2000 genes were kept. Cells containing more than 5% of mitochondrial reads were excluded from downstream analyses. Downstream analyses were performed using the R package Seurat version 4.0. Each scRNA-seq dataset was scaled by library size and log-transformed and for each sample the top 2000 most variable genes were identified. Data were scaled to unit variance and zero mean and the dimensionality of the data was reduced by principal component analysis (PCA) (15 components) and visualized with t-distributed stochastic neighbor embedding (t-SNE) or Uniform Minifold Approximation and Projection (UMAP). Clustering was performed using the Louvain algorithm on the 15 principal components (resolution = 0.5). Cluster-specific markers were identified with the “FindAllMarkers” function.

2.4. Immunocytochemistry

Approximately 2.5 × 104 of CAFs/DAFs were seeded on the slides and incubated overnight. PANC-1 cells were used in addition as control for epithelial cell adhesion molecule (EpCAM) staining. Cells were then fixed with 4% PFA and sequentially immunostained with antibodies directed against alpha-smooth muscle actin (α-SMA) (Invitrogen, 701457), KRT19 (Invitrogen, MA5-31977, Waltham, MA, USA), C-X-C motif chemokine 12 (CXCL12) (Invitrogen, PA5-114344), or EpCAM (Dako, M0804).

2.5. GEPIA

For gene expression profiling and overall survival analysis, we conducted bioinformatics analysis on the GEPIA platform using the Kaplan–Meier survival plots tool [14], as described previously [15]. Our analysis included 176 to 178 pancreatic cancer samples based on the Cancer Genome Atlas (TCGA) database. Median expression was used as the threshold between high and low expression. p < 0.05 was considered statistically significant.

2.6. Data Access

Sequencing raw data are available at European Genome-Phenome Archive (EGA) box with the accession number EGAS00001005889.

3. Results

3.1. Identification of Highly Variable Genes in Disease-Associated Fibroblasts of Pancreatic Cancer and Chronic Pancreatitis Patients

To study previously described myCAF, iCAF, or apCAF subtypes, and investigate potentially altered CAF states in pancreatic cancer (patient1 and patient2) and chronic pancreatitis patients (patient3) in our cohort (Table 1), we isolated primary disease-associated fibroblasts (DAFs) and performed single-cell RNA sequencing (scRNA-seq) analysis. We selected the outgrowth method, because it is a widely recognized and established method for isolating CAFs. To validate the absence of tumor cells in our samples, we performed immunocytochemistry against EpCAM. We observed positive staining of EpCAM in PANC-1 pancreatic cancer cells, but no positivity was observed in isolated DAFs (Figure 1). After quality control, we obtained 2714, 6764, and 7639 cells, respectively (Table 1). CAFs from patient1 showed several highly variable genes that contribute strongly to cell-to-cell variation, including Insulin Growth Factor Binding Proteins IGFBP3 and IGFBP5, Set- and Mynd Domain Containing 3 (SMYD3), Neurofilament Light Chain (NEFL), Keratin 19 (KRT19), Matrix Metalloprotease 1 (MMP1), MMP3, metastasis suppressor KISS1, Growth Differentiation Factor 15 (GDF15), Pentraxin 3 (PTX3), S100 Calcium Binding Protein A4 (S100A4), and Interferon Alpha Inducible Protein 27 (IFI27) (Figure 2A). In CAFs from patient2, we detected chemokines CXCL1, CXCL3, CXCL8, Interleukin 1B (IL1B), MMP1, MMP3, Heat Shock Protein Family A Member 5 (HSPA5, also known as GRP78 or BiP), Proteoglycan 4 (PRG4), RAS-related Glycolysis Inhibitor And Calcium Channel Regulator (RRAD), and HIST1H4C (Figure 2B). In the fibroblasts from patient3, we detected IGFBP5, SMYD3, MMP1, TIMP1, Serpin Family E Member 2 (SERPINE2), KRT18, G0/G1 Switch 2 (G0S2), ADAM Metallopeptidase with Thrombospondin Type 1 Motif 18 (ADAMTS18), and HIST1H4C (Figure 2C). To examine whether expression of above mentioned 25 factors is associated with pancreatic cancer patient survival, we performed overall survival (OS) analysis on the GEPIA platform. We identified that expression of IFI27, KRT18, KRT19, MMP1, MMP3, and NEFL are associated with a shorter overall survival of pancreatic cancer patients (Figure 3), whereas the expression of the other 16 genes are not associated with the overall survival of pancreatic cancer patients (not shown). It has been previously shown with a lineage-labeling approach that CAFs of non-PSC origin exhibited elevated expression of KRT8, KRT18, and KRT19 [16]. Interestingly, we observed both KRT19-positive and KRT19-negative fibroblasts by immunocytochemistry in all three cases (Figure 4).
Table 1

Information of the patients and analyzed number of single cells.

Title 1Patient1Patient2Patient3
Age at the resection794825
gendermalefemalemale
Disease, Tumor classificationPancreatic cancer, G2 pT3 pN1 M0, L0 V0 Pn1, UICC-Status IIBPancreatic cancer, G2 pT2 pN0 M0, L0 V0 Pn1, UICC-Status IBChronic pancreatitis
Number of nuclei271467647639
Figure 1

Immunocytochemistry of EpCAM in disease-associated fibroblasts from pancreatic cancer and chronic pancreatitis patients. (A) Panc-1 cells stained as positive control, (B) cells from patient1, (C) from patient2, and (D) from patient3. Bar: 50 μm.

Figure 2

Highly variable features in disease-associated fibroblasts from pancreatic cancer and chronic pancreatitis patients. A subset of features that exhibit high variation between cells in disease-associated fibroblasts (A) from patient1, (B) from patient2, and (C) from patient3.

Figure 3

Analysis of 6 genes and overall survival. Overall survival analyses of 6 genes (IFI27, KRT18, KRT19, MMP1, MMP3, and NEFL) in pancreatic cancer based on the GEPIA database. Median expression was used as the threshold between high and low expression. The 95% confidence interval is plotted by the dotted lines.

Figure 4

Immunocytochemistry of KRT19 in disease-associated fibroblasts from pancreatic cancer and chronic pancreatitis patients. (A) from patient1, (B) from patient2, and (C) from patient3. Bar: 50 μm.

3.2. Cell Cycle-Associated Factors Are Majority of Highly Variable Genes

Next, to identify which factors are co-expressed together in CAFs/DAFs, we performed heat map analyses and show the top differentially expressed genes in 3 panels for each patient (Figure 5). The analyses revealed that the variance was mostly covered by cell-cycle genes including MKI67, CENPF, and CCNB1 (Figure 5). To mitigate the effects of cell cycle heterogeneity in scRNA data, we performed cell cycle regression analysis as previously demonstrated [17]. Prior to cell cycle regression, we observed 9 clusters of cells with similar expression profiles produced by the t-distributed stochastic neighbor embedding (t-SNE) algorithm in CAFs from patient1, 10 clusters in CAFs from patient2, and 11 clusters in fibroblasts from patient3 (Figure 6A–C). After cell cycle regression, we did not observe clearly distinct clusters (Figure 6D–F), suggesting that (1) signals derived from cell cycle-associated factors strongly impact on cluster heterogeneity presentation, and (2) primary isolated and cultured cells are not unique population but exhibit highly similar expression profiling between the clusters. We were still able to divide clusters 0 to 3 in CAFs from patient1, clusters 0 to 3 in CAFs from patient2, as well as clusters 0 to 4 in DAFs from patient3 (Figure 6D–F). We summarize highly variable features after cell cycle regression in Table 2 (patient1), Table 3 (patient2), and Table 4 (patient3). Among 25 highly variable genes identified before cell cycle regression, two factors namely IGFBP3 and IGFBP5 were identified as highly variable genes even after cell cycle regression (Table 2, Cluster 0 in Figure 2D), suggesting that these two genes may contribute to CAF heterogeneity independent of cell cycle stage. Interestingly, a number of factors, cell cycle-associated but also non-cell-cycle-associated factors, are identified as highly variable genes shared between CAFs/DAFs isolated from chronic pancreatitis and pancreatic cancer patients (Table 5).
Figure 5

Heat map analyses of scRNAseq data of disease-associated fibroblasts from pancreatic cancer and chronic pancreatitis patients. Top differentially expressed genes were summarized as 3 selected heat map panels in disease-associated fibroblasts (A) from patient1, (B) from patient2, and (C) from patient3.

Figure 6

Dimensionality reduction of scRNAseq data. The t-SNE plot analysis of scRNAseq data prior to cell cycle regression (A) from patient1, (B) from patient2, and (C) from patient3. The Uniform Minifold Approximation and Projection (UMAP) plot analysis after cell cycle regression (D) from patient1, (E) from patient2, and (F) from patient3.

Table 2

Highly variable genes after cell cycle regression in CAFs isolated from Patient1.

GeneClusterp-ValueAverage log2FC Pct.1Pct.2p-Value Adjusted
MXD4 05.03 × 10−1150.526576753357570.8890.5081.16 × 10−110
PAPPA 09.83 × 10−861.01090908992620.8420.5512.27 × 10−81
GDF15 02.41 × 10−731.169722436943660.6290.2815.57 × 10−69
CDC42EP5 03.35 × 10−690.3296951534078110.6510.2947.75 × 10−65
SAT1 07.20 × 10−640.6047526742790490.8660.6181.66 × 10−59
THBS2 03.09 × 10−570.4209629225897720.9050.6567.14 × 10−53
CTSK 01.11 × 10−560.9225473665162970.7130.4422.57 × 10−52
COX7A1 01.63 × 10−560.4819231741874650.7770.5023.76 × 10−52
SNRPN 03.29 × 10−550.3675553283933670.9050.6797.62 × 10−51
FADS3 02.22 × 10−510.3726444805417740.8420.5935.12 × 10−47
PCDH10 03.71 × 10−500.3883621897184030.5620.2488.58 × 10−46
SCG5 01.47 × 10−470.8973138356833020.6840.4143.40 × 10−43
IGFBP5 06.23 × 10−471.896062457607680.6480.3881.44 × 10−42
AHNAK2 01.58 × 10−450.3426191428250.740.4383.66 × 10−41
C5orf46 02.85 × 10−440.4343349364218860.6020.326.60 × 10−40
AC097480.1 03.92 × 10−440.3974202953681660.3760.1179.07 × 10−41
CRYAB 04.14 × 10−410.7195317392176650.7950.5549.58 × 10−37
IGFBP3 02.10 × 10−401.307674484510240.6910.4354.85 × 10−36
ANGPTL4 03.34 × 10−400.3551062236708630.5430.2567.73 × 10−36
FSTL3 09.44 × 10−380.3320608876114380.7610.4912.18 × 10−33
COPZ2 02.37 × 10−370.3266114623066430.8910.6785.48 × 10−33
GPNMB 03.63 × 10−350.3532413392243020.7610.5228.38 × 10−31
LMCD1 04.55 × 10−340.5054629914518270.6350.3951.05 × 10−29
LUM 07.07 × 10−290.4074775322694380.690.4541.63 × 10−24
COL11A1 08.50 × 10−270.4107162096115680.590.3491.96 × 10−23
ANKRD37 01.84 × 10−260.3574219758132580.4740.2314.26 × 10−22
KIF26B 01.09 × 10−240.4540039547542780.6970.4492.53 × 10−19
CYP1B1 02.93 × 10−210.3109035027620830.4730.2456.78 × 10−17
ABI3BP 05.40 × 10−210.5045781029689740.4020.1921.25 × 10−16
CDK1 13.38 × 10−2811.2177737012710.9230.2327.81 × 10−277
HJURP 18.28 × 10−2140.6660945354234770.7760.1481.91 × 10−210
UBE2C 11.45 × 10−2111.55850902169380.9370.4073.36 × 10−207
TOP2A 11.19 × 10−2061.542717935372390.9360.4352.76 × 10−202
AURKB 13.29 × 10−2050.746161425403910.8470.237.60 × 10−201
FBXO5 11.02 × 10−2030.675121756130250.8730.2492.35 × 10−199
HIST1H1B 13.44 × 10−1951.459221645577410.7770.1857.95 × 10−191
CDCA2 11.35 × 10−1880.6923305897730160.8250.2223.12 × 10−184
KIF18B 16.20 × 10−1880.561459368366750.750.1551.43 × 10−183
CDCA8 13.90 × 10−1790.7526587396982570.8370.2269.02 × 10−175
CKAP2L 18.64 × 10−1790.604697457008970.8210.2212.00 × 10−174
ARHGAP11B 17.96 × 10−1720.5501610238212820.7130.1521.84 × 10−167
CEP128 15.52 × 10−1700.5866771781926010.820.2371.28 × 10−165
HMGB2 17.70 × 10−1691.248120176815730.9580.531.78 × 10−164
LINC01572 19.80 × 10−1550.6339461216867110.7870.2632.27 × 10−151
MELK 13.91 × 10−1510.5659607490661640.8650.3359.05 × 10−147
ESCO2 11.19 × 10−1470.4809350137694910.7540.2022.76 × 10−143
GTSE1 16.96 × 10−1470.7272463062467620.8440.3171.61 × 10−142
NCAPG 18.42 × 10−1470.6577841934308860.8880.3481.95 × 10−142
KIFC1 11.29 × 10−1450.523830575415410.8030.252.99 × 10−140
KIF23 12.14 × 10−1430.7710388334430010.8950.4414.95 × 10−139
NEIL3 17.34 × 10−1430.3728244444693210.6260.1181.70 × 10−139
DLEU2 14.85 × 10−1400.6285953092887410.9330.51.12 × 10−135
KIF11 13.37 × 10−1370.5700917391201920.8330.2987.79 × 10−133
NDC80 15.48 × 10−1360.5738732853682150.8210.2711.27 × 10−131
NSD2 16.78 × 10−1340.6830289688447980.9730.6041.57 × 10−129
UBE2T 12.76 × 10−1330.7175758755067570.970.6216.38 × 10−129
CDCA5 13.45 × 10−1290.3960313257431750.7060.1827.99 × 10−125
KNL1 12.60 × 10−1270.5900679394281050.8270.3116.02 × 10−124
CENPK 11.68 × 10−1260.5957730015263770.9330.4893.88 × 10−123
BARD1 11.05 × 10−1240.4976216179040680.8470.3412.43 × 10−120
MKI67 13.50 × 10−1240.9906472906021040.9180.4828.09 × 10−120
KIF20B 18.54 × 10−1220.6788201116860730.9150.4281.97 × 10−117
TTK 11.72 × 10−1180.391985169692140.6330.153.98 × 10−114
SMC4 13.37 × 10−1180.8310721415666860.9740.6627.79 × 10−114
CDCA4 19.86 × 10−1180.4621525502744660.8180.3452.28 × 10−113
KIF4A 15.43 × 10−1170.5069690081895710.8030.2991.26 × 10−112
FEN1 13.23 × 10−1160.5813378240599990.910.4567.46 × 10−112
NUF2 14.54 × 10−1160.6461074354940530.8360.3351.05 × 10−110
KIF14 15.91 × 10−1150.4636925242193730.7050.2121.37 × 10−110
DBF4 11.95 × 10−1140.5878341469018010.8580.4364.52 × 10−110
SPC25 11.04 × 10−1130.5213053254885450.8180.3232.40 × 10−109
KIF2C 11.08 × 10−1130.5129910641383380.7270.2232.49 × 10−109
CCNA2 11.33 × 10−1130.588585929219460.8480.3373.09 × 10−109
FAM83D 11.36 × 10−1140.3882591463996280.6130.1543.14 × 10−109
KIF15 14.23 × 10−1120.3086097901696680.5930.1349.78 × 10−108
HIST1H1E 18.84 × 10−1120.9309710714630360.7190.3062.04 × 10−107
SGO1 11.18 × 10−1110.4142782444618170.7190.2182.73 × 10−107
CLSPN 12.91 × 10−1110.655089144831090.9560.5016.73 × 10−107
HIST1H2AH 17.15 × 10−1110.3752168482973760.4710.0771.65 × 10−106
TMPO 12.97 × 10−1100.7071332230142090.9730.6926.87 × 10−106
BRIP1 13.94 × 10−1100.6102590587818360.8630.3929.10 × 10−106
HIST1H3B 16.36 × 10−1100.3390099766049040.4920.0881.47 × 10−105
CENPE 12.31 × 10−1090.838685214933310.8360.3855.35 × 10−105
ATAD2 13.36 × 10−1100.6464185487261520.9440.5337.76 × 10−105
MIR924HG 11.87 × 10−1080.609124256103840.7340.2384.32 × 10−104
FAM111A 14.28 × 10−1080.4800665688636140.7570.3219.90 × 10−104
POLQ 15.56 × 10−1070.3268871740802240.6190.1561.29 × 10−102
Z94721.1 16.30 × 10−1060.3112909526554720.5680.1291.46 × 10−101
ASPM 16.94 × 10−1060.8064766677278350.8520.3811.60 × 10−101
KIF18A 12.04 × 10−1050.4579851148612870.7640.3074.71 × 10−101
HIST1H3D 16.05 × 10−1050.388950991417060.4890.0941.40 × 10−100
MIS18BP1 18.74 × 10−1040.5433886388035410.9230.592.02 × 10−100
NCAPH 19.30 × 10−1040.3184416691679830.6430.1772.15 × 10−99
H2AFX 19.41 × 10−1040.6857033326434430.940.6322.18 × 10−99
ARHGAP11A 14.07 × 10−1030.4324325646008060.6980.2439.42 × 10−99
TACC3 11.13 × 10−1020.5841233764643010.8650.4052.61 × 10−98
BUB1B 11.58 × 10−1010.4503863181250730.740.2573.65 × 10−97
CCDC18 11.78 × 10−1010.5018832740337250.7860.3554.11 × 10−97
ANLN 18.20 × 10−1000.6867406186925370.9220.5051.90 × 10−95
RAD51AP1 13.03 × 10−990.3853454882786630.7580.2777.01 × 10−95
CIT 15.55 × 10−990.4256356725385820.6780.231.28 × 10−94
CCNF 13.61 × 10−970.3097201896427150.5330.1248.35 × 10−93
CENPU 13.42 × 10−960.5170989494419270.9210.4827.91 × 10−92
USP1 14.73 × 10−970.5296224212088180.9280.591.09 × 10−91
ARHGAP11A 14.07 × 10−1030.4324325646008060.6980.2439.42 × 10−99
TACC3 11.13 × 10−1020.5841233764643010.8650.4052.61 × 10−98
BUB1B 11.58 × 10−1010.4503863181250730.740.2573.65 × 10−97
CCDC18 11.78 × 10−1010.5018832740337250.7860.3554.11 × 10−97
ANLN 18.20 × 10−1000.6867406186925370.9220.5051.90 × 10−95
RAD51AP1 13.03 × 10−990.3853454882786630.7580.2777.01 × 10−95
CIT 15.55 × 10−990.4256356725385820.6780.231.28 × 10−94
CCNF 13.61 × 10−970.3097201896427150.5330.1248.35 × 10−93
CENPU 13.42 × 10−960.5170989494419270.9210.4827.91 × 10−92
USP1 14.73 × 10−970.5296224212088180.9280.591.09 × 10−91
GAS2L3 15.48 × 10−960.4404484977798580.6410.2141.27 × 10−91
CENPI 11.43 × 10−950.3138200832412180.6110.1763.31 × 10−91
RRM2 11.66 × 10−950.6435119704290960.9450.5583.83 × 10−91
CENPA 18.64 × 10−950.5111350303947210.6820.2442.00 × 10−90
SKA3 15.87 × 10−940.3245960624841810.6790.2211.36 × 10−89
ZWINT 11.05 × 10−920.5317993716265740.9190.5362.43 × 10−88
NUSAP1 11.96 × 10−920.6935608435916110.9180.5224.53 × 10−88
SGO2 11.41 × 10−900.5800559321487880.8250.3943.27 × 10−86
SHCBP1 13.79 × 10−890.4482477402549580.8690.4048.76 × 10−85
DNAJC9 18.51 × 10−890.5194794388579250.9750.771.97 × 10−83
ASF1B 11.37 × 10−870.3431592105324760.690.2393.16 × 10−83
HIST2H2AC 11.63 × 10−870.6799804546031950.7230.363.78 × 10−83
C21orf58 11.34 × 10−860.3082642980868680.6380.2033.11 × 10−82
BRCA1 14.39 × 10−860.3782105647810650.7760.3181.02 × 10−81
GMNN 13.35 × 10−850.4839395042505890.9170.567.74 × 10−81
ORC6 14.22 × 10−850.3982670824948430.8010.3459.76 × 10−81
MND1 11.25 × 10−840.3242917437596010.6790.2352.88 × 10−81
CENPF 11.95 × 10−830.9614606309936160.9210.5514.50 × 10−79
MXD3 11.44 × 10−810.364407680703720.5660.1773.33 × 10−77
RRM1 13.17 × 10−810.4746048695675640.940.6557.33 × 10−77
HIST1H1A 11.80 × 10−800.7106056806790220.4930.1374.16 × 10−76
MAD2L1 15.20 × 10−800.4894887504555220.9080.5131.20 × 10−75
AURKA 11.24 × 10−790.630541876070670.8250.422.86 × 10−74
ECT2 19.18 × 10−780.4462602410030610.8370.4662.12 × 10−73
RACGAP1 13.16 × 10−770.3570603537013380.7320.3047.30 × 10−73
CDC45 12.22 × 10−760.3088404943795320.7090.2725.14 × 10−72
RFC3 13.01 × 10−760.3433522188483340.7690.3216.97 × 10−73
PBK 13.17 × 10−750.5676118389472070.9190.4997.32 × 10−71
PKMYT1 13.47 × 10−740.3060898757920540.6540.2358.03 × 10−70
BRCA2 11.42 × 10−730.349650530114710.7040.2813.28 × 10−69
MYBL1 13.34 × 10−720.3492266562304260.6820.2967.72 × 10−68
PIF1 18.17 × 10−720.3384132598228570.4480.1221.89 × 10−67
TPX2 19.93 × 10−720.6642861559404320.930.6052.30 × 10−67
FANCI 18.02 × 10−710.3345010154489170.7980.3691.85 × 10−66
HELLS 12.83 × 10−700.4362945414482650.8780.5046.55 × 10−66
CENPP 13.61 × 10−700.4292434168951060.7690.3868.34 × 10−66
PRIM2 19.54 × 10−700.4456631133729040.9260.6152.21 × 10−65
TCF19 12.05 × 10−690.3069779900835550.6820.2654.75 × 10−67
LMNB1 11.72 × 10−680.3349398805298080.7510.3173.99 × 10−64
MIS18A 12.62 × 10−680.3518946004978540.770.396.06 × 10−64
CIP2A 13.52 × 10−680.354135555586720.7580.3518.15 × 10−64
NAV2 15.25 × 10−680.7159670193613790.9070.6981.21 × 10−63
EZH2 19.96 × 10−680.3303768301760610.7790.3542.30 × 10−63
POLD3 11.03 × 10−670.3465270033876370.7470.3582.38 × 10−63
SPATA5 11.55 × 10−670.4244386108467980.8330.5013.58 × 10−63
NCAPG2 16.97 × 10−670.3700944931589390.8020.4131.61 × 10−62
VRK1 11.58 × 10−660.3508281988238950.7950.4113.64 × 10−62
SCLT1 12.50 × 10−660.5385678844841860.8810.6395.78 × 10−62
G2E3 11.41 × 10−650.4349314817142170.8090.5183.26 × 10−61
HIST1H1C 16.02 × 10−650.7494710256328110.7920.5331.39 × 10−60
PCLAF 17.63 × 10−650.5484095425400110.9820.7261.76 × 10−60
CEP55 12.28 × 10−640.4443848777216660.8830.4485.26 × 10−60
AP001347.1 12.65 × 10−640.3388604904596120.6970.3066.13 × 10−60
RAD18 13.64 × 10−620.3495110344277670.8130.4648.42 × 10−58
MYBL2 14.80 × 10−620.3275992708263760.7010.3091.11 × 10−57
APOLD1 11.04 × 10−610.4827058296259380.7140.3562.40 × 10−57
PSMC3IP 13.62 × 10−600.3057279700417190.7750.3668.37 × 10−56
MCM7 15.97 × 10−590.4064257236660960.9470.5751.38 × 10−54
GPSM2 11.11 × 10−570.3563752376104960.6530.2992.58 × 10−53
NCAPD3 11.47 × 10−550.3234523796032210.810.473.39 × 10−51
CKAP2 11.48 × 10−550.5496409774391340.8720.6023.42 × 10−51
CDKN2D 15.12 × 10−540.4416255405928130.6830.3871.18 × 10−49
SMC2 11.35 × 10−530.3824962334630840.930.6713.11 × 10−49
BUB1 11.40 × 10−530.3117224215210020.6990.3073.24 × 10−49
FOXM1 12.19 × 10−530.3008150928231510.750.3785.06 × 10−50
TEX30 13.39 × 10−510.3191356475696590.8420.5467.84 × 10−47
PRR11 16.78 × 10−520.3834341897935990.8030.4441.57 × 10−46
GINS2 11.38 × 10−500.3657511947700390.8850.5263.20 × 10−45
EMP2 15.82 × 10−510.349245508301570.8720.61.34 × 10−44
TRIM59 17.84 × 10−480.3917219613734520.7720.5061.81 × 10−43
HIST1H1D 13.16 × 10−470.4400654112596820.3310.0817.30 × 10−43
HMMR 15.48 × 10−460.4066883505088690.8390.4411.27 × 10−41
SMC1A 12.73 × 10−450.343722404443550.8950.6786.31 × 10−41
CCDC14 13.02 × 10−460.3285660077070110.8010.5076.98 × 10−41
KIF22 15.25 × 10−450.3060368000595920.7770.4791.21 × 10−40
PLK1 13.34 × 10−440.4179987459390950.6780.3367.73 × 10−39
LCORL 11.35 × 10−420.3889233890397010.7760.5213.13 × 10−38
DEPDC1 13.55 × 10−420.3258698729556020.7420.378.21 × 10−38
SAC3D1 14.47 × 10−410.3219927206323060.8950.6771.03 × 10−36
PRC1 15.34 × 10−400.4346597577674060.9340.5811.23 × 10−35
DHFR 13.09 × 10−390.3159863927759520.9080.6867.14 × 10−35
CENPM 11.11 × 10−380.3249648229195660.9060.6152.56 × 10−34
BIRC5 17.70 × 10−350.402211600650420.9450.6551.78 × 10−30
RFX8 11.72 × 10−340.3054492069692170.6540.3623.98 × 10−29
SAP30 16.59 × 10−310.3208961819971670.7830.5691.52 × 10−26
RAD51B 11.46 × 10−290.3670033203281780.8130.5943.38 × 10−24
KNSTRN 11.59 × 10−220.3027227976319730.7640.5523.67 × 10−18
CCNB1 21.38 × 10−1701.281304091891540.9970.653.19 × 10−166
CDC20 26.96 × 10−1491.080853101407980.9750.511.61 × 10−144
CCNB2 21.08 × 10−1470.799636475539270.9380.4282.51 × 10−143
DLGAP5 22.02 × 10−1270.7761398718997890.940.4274.68 × 10−123
PRC1 22.18 × 10−1170.8700568696437960.9870.5895.03 × 10−113
HMMR 23.01 × 10−1140.7542713723595690.9430.4376.95 × 10−110
CDKN3 25.32 × 10−1110.7692256210459130.9930.6911.23 × 10−106
BIRC5 23.17 × 10−980.7355387459565020.9870.6627.33 × 10−94
CKS1B 22.03 × 10−940.6910596053941960.990.754.70 × 10−88
TPX2 24.90 × 10−920.809608519905480.9780.6121.13 × 10−87
CENPF 23.71 × 10−910.8576617642497160.9920.5558.59 × 10−87
CDCA3 26.47 × 10−890.5453694443723270.8710.4191.50 × 10−84
PBK 23.82 × 10−840.65539133933870.9530.5178.83 × 10−80
DEPDC1 29.19 × 10−810.5621610535683710.8110.3742.13 × 10−76
CEP55 21.67 × 10−770.6175795526002430.8910.4733.86 × 10−74
PIMREG 21.84 × 10−750.4696409390186830.7550.3524.25 × 10−71
PHF19 27.36 × 10−730.5226954992271470.9460.671.70 × 10−68
NUSAP1 22.76 × 10−590.5107025026167560.9430.546.38 × 10−55
PLK1 21.76 × 10−580.437956854322610.7450.3384.06 × 10−54
MAD2L1 23.55 × 10−540.4929089834975930.8980.5418.21 × 10−50
CKAP2 26.02 × 10−490.5980438428894730.8640.6211.39 × 10−44
SMC4 21.88 × 10−470.5254587382440710.9770.6814.34 × 10−43
MKI67 27.10 × 10−470.4600756586034730.9430.5031.64 × 10−42
ANLN 21.47 × 10−460.4343408958765650.9210.5323.39 × 10−42
NEK2 21.14 × 10−450.3075807084808620.5260.2112.63 × 10−41
PRR11 24.65 × 10−460.3680304295157340.8110.4651.08 × 10−41
BUB1 21.91 × 10−360.3175683788068360.6570.3444.43 × 10−32
TMPO 25.74 × 10−340.4298726358356130.9480.7171.33 × 10−29
ASPM 21.36 × 10−330.3962226941735030.7890.4293.14 × 10−29
TACC3 21.11 × 10−320.3329361071977240.8010.4532.56 × 10−28
MSH6 22.77 × 10−310.3366690264986780.7470.536.40 × 10−27
KNSTRN 29.43 × 10−300.406401583054180.7650.5652.18 × 10−25
PCLAF 22.54 × 10−280.4125862218877050.9870.7415.87 × 10−24
H2AFX 25.65 × 10−260.3451020894853940.8860.6671.31 × 10−20
CENPE 27.96 × 10−240.315174779231080.7570.4361.84 × 10−19
AURKA 21.16 × 10−210.4549907933951690.7050.4792.68 × 10−17
KIF20B 21.19 × 10−230.3430444243821520.7810.4972.76 × 10−17
RRM2 21.22 × 10−220.3154125490991770.9010.5952.81 × 10−17
NUF2 21.01 × 10−200.313692992471810.70.4052.34 × 10−16
MCM7 21.11 × 10−180.3023973587387160.8440.6282.56 × 10−14
SGO2 25.42 × 10−160.3281465287751390.6870.461.25 × 10−11
Table 3

Highly variable genes after cell cycle regression in CAFs isolated from Patient2.

GeneClusterp-ValueAverage log2FCPct.1Pct.2p-Value Adjusted
TOP2A 001.796053263746940.8150.2330
UBE2C 001.639194452119540.7810.2110
CENPF 001.348761241171040.8110.2920
CDK1 001.332646662023550.7740.1380
STMN1 001.321386824515920.9420.5470
NUSAP1 001.22869807350270.7920.2380
DIAPH3 001.161139076547030.8510.2950
CKS2 001.152931018117740.9220.620
HMGB2 001.115385350173220.7680.2460
TYMS 001.100006189983480.8660.3140
MKI67 001.075806736151010.7310.2040
SMC4 000.9859215983785380.8460.440
PCLAF 000.9683238197924440.8820.2960
TPX2 000.9243588945141240.7690.2660
ASPM 000.8976702494203660.6780.1820
CLSPN 000.8871719129270920.7570.1760
ATAD2 000.8747515263798460.7750.2370
PBK 000.8557849444662620.7350.220
CENPU 000.8351177570984710.7820.1960
CKS1B 000.8334352037276370.8760.4540
UBE2T 000.8259645408090450.7850.2750
RRM2 000.824061835005470.6630.1610
KIF20B 000.8157764786470660.7360.2070
APOLD1 000.7971400871610040.6030.1560
CENPK 000.7931379750199390.8050.2610
CENPE 000.7926149846662220.6730.190
TACC3 000.7669152473579030.7050.1990
TMPO 000.7399474103441410.750.2670
ANLN 000.7323498670274080.6910.2060
SGO2 000.7291811049408370.6930.2090
TK1 000.7243863385452940.7830.2380
HMMR 000.6991728425469250.6450.1610
NCAPG 000.6973193710705760.6450.1240
FEN1 000.6968926682322850.7060.1970
SPC25 000.6817633275641780.6350.1280
HJURP 000.6797935952900090.5560.0860
FBXO5 000.6716201013187950.6110.1130
NUF2 000.6409120058590670.6110.1480
HELLS 000.634515078119570.6470.170
NDC80 000.6214131140067060.6160.1410
GTSE1 000.6199829666001720.60.1450
AURKB 000.6068847644501410.5580.0920
KIF23 000.6024777693032730.6050.1450
ZWINT 000.5984165029530590.6560.1750
KNL1 000.5833677842437980.5840.1270
KIF11 000.5727097715870860.5780.1310
CDCA8 000.5385165998819070.5120.0890
CKAP2L 000.5084869545857480.5240.0960
CEP128 000.4858318272547040.50.0860
MELK 000.4822592109275120.5380.1060
ESCO2 04.69 × 10−2950.4439422173365550.4690.0731.12 × 10−289
PSMC3IP 02.56 × 10−2930.5347138227802040.6120.1616.12 × 10−289
AURKA 05.53 × 10−2880.698483702894140.620.1641.32 × 10−283
NSD2 06.07 × 10−2870.6729944365416580.7190.2681.45 × 10−282
BRIP1 01.73 × 10−2860.5006898989637520.4690.0784.15 × 10−282
MXD3 03.37 × 10−2860.525437944123120.4880.0928.08 × 10−282
CEP55 01.45 × 10−2820.6262505268553520.6620.1873.46 × 10−278
ARHGAP11B 05.82 × 10−2820.4324703731389730.4260.061.39 × 10−277
KIF14 06.53 × 10−2790.4584598933204240.4790.0851.56 × 10−275
KPNA2 06.13 × 10−2771.118847769189330.8690.5551.47 × 10−272
RFC3 08.41 × 10−2770.4686356219073170.570.1372.01 × 10−272
CCNA2 01.27 × 10−2760.6011841177024510.5810.1463.04 × 10−273
H2AFX 04.76 × 10−2750.7729133823458420.7340.3141.14 × 10−270
BIRC5 01.80 × 10−2740.8112772064117670.7670.274.31 × 10−269
CENPM 03.93 × 10−2730.5424347093916090.670.2029.40 × 10−269
CENPW 01.75 × 10−2720.721484699260980.8160.3454.20 × 10−268
HIST1H1B 01.11 × 10−2710.7072089119307340.410.0592.66 × 10−268
PRC1 02.52 × 10−2710.7455066413675810.7460.2616.03 × 10−268
PCNA 02.34 × 10−2700.7184227235314820.8090.3955.60 × 10−266
SHCBP1 01.48 × 10−2680.4516448022041190.5590.1293.55 × 10−264
DNAJC9 09.37 × 10−2670.6339496720862130.7810.3472.25 × 10−262
KIFC1 03.26 × 10−2660.410480609282040.4780.0897.80 × 10−262
DTL 09.05 × 10−2650.4049512771721610.4280.0682.17 × 10−260
RAD51AP1 02.77 × 10−2640.4178405912870330.4780.0926.64 × 10−260
GINS2 06.91 × 10−2640.4603870445132580.5120.111.65 × 10−259
CDCA5 07.00 × 10−2620.3475876176028580.4090.0581.68 × 10−257
KIF18B 03.05 × 10−2610.3824580428162940.4040.0577.30 × 10−257
BARD1 08.79 × 10−2600.4240843840254790.4620.0862.11 × 10−255
SGO1 08.35 × 10−2590.412900781418430.4720.092.00 × 10−254
KIF4A 03.33 × 10−2550.4724998593569290.50.1097.97 × 10−251
TTK 07.37 × 10−2550.3667754516120810.4190.0661.76 × 10−250
DTYMK 01.18 × 10−2540.70262255216640.9130.5932.82 × 10−250
ORC6 09.10 × 10−2540.431595774645650.530.1262.18 × 10−249
LINC01572 04.59 × 10−2520.4247170027775510.4290.0741.10 × 10−247
MAD2L1 06.58 × 10−2520.5773049391251780.6990.2471.57 × 10−247
MYBL1 02.37 × 10−2490.3657844216165950.4150.0665.67 × 10−245
CKAP2 01.65 × 10−2480.7455627125447660.7470.313.95 × 10−244
KIF2C 06.83 × 10−2460.4361365809589060.4560.091.64 × 10−241
NEIL3 01.20 × 10−2450.3461159861296780.3770.0512.88 × 10−241
SMC2 08.54 × 10−2430.6088757251698780.8210.4112.05 × 10−238
MCM7 01.14 × 10−2410.4932204883974210.6520.2132.73 × 10−237
BRCA1 07.42 × 10−2360.4226946888180540.5090.1241.78 × 10−231
DLGAP5 02.32 × 10−2350.5846379126448740.6180.1855.56 × 10−231
DEPDC1 02.39 × 10−2350.4978676504484420.5740.1565.73 × 10−231
RRM1 03.05 × 10−2350.5319607192188360.7240.2927.30 × 10−231
DNMT1 07.81 × 10−2350.6102187710913250.8540.4741.87 × 10−230
FANCI 05.13 × 10−2330.414202437430290.5210.1331.23 × 10−228
CENPH 01.86 × 10−2320.4485727673628750.6420.2074.46 × 10−228
BUB1B 03.53 × 10−2310.4155123819003520.4810.1088.46 × 10−227
CDC25C 05.81 × 10−2310.3805666468870020.4030.071.39 × 10−226
NCAPH 01.11 × 10−2290.3182747518782980.3910.0632.66 × 10−226
CENPX 01.39 × 10−2260.6393734594168580.9220.6513.32 × 10−222
PHF19 05.15 × 10−2260.5412014000548870.6960.2621.23 × 10−221
NCAPG2 03.70 × 10−2240.4318464556338520.5390.1498.86 × 10−220
KIF18A 01.53 × 10−2230.4210644202104070.480.1143.67 × 10−219
CDCA2 02.31 × 10−2230.4493411376196280.5060.1335.54 × 10−219
PRR11 01.29 × 10−2210.4871108802470230.5610.1613.08 × 10−217
E2F1 02.84 × 10−2210.397883868268940.4730.116.81 × 10−217
CENPN 06.53 × 10−2200.4800544727918420.670.2461.56 × 10−215
CDCA3 03.89 × 10−2180.5620710825331520.590.1859.32 × 10−214
DLEU2 07.17 × 10−2160.4965165802123330.6230.2181.72 × 10−210
GMNN 02.80 × 10−2140.5588707245620770.7290.3196.71 × 10−210
CCDC18 03.73 × 10−2140.4680518898732880.5580.1738.93 × 10−210
CDC45 01.24 × 10−2130.3157902943591640.3830.0662.97 × 10−209
PTTG1 06.60 × 10−2130.7773912963158420.8810.5171.58 × 10−208
RPL39L 06.71 × 10−2130.5573967673502970.7290.3271.61 × 10−208
MND1 01.89 × 10−2110.3157145894774280.370.0614.52 × 10−207
ITGB3BP 03.64 × 10−2100.5160683513042910.7260.3188.73 × 10−206
BRCA2 09.28 × 10−2110.3422725832841520.4420.0972.22 × 10−206
SPDL1 03.71 × 10−2090.6158518550505380.8260.478.89 × 10−205
RACGAP1 02.33 × 10−2040.4029725744245270.50.1365.58 × 10−200
SKA2 03.70 × 10−2030.5386459908357650.8360.4558.87 × 10−199
CENPA 01.63 × 10−2020.4925270345671370.5130.1493.91 × 10−198
BUB1 04.01 × 10−2020.3572044729780740.4590.1099.60 × 10−198
ARHGAP11A 01.47 × 10−1990.3538842465641750.4220.0933.53 × 10−196
NASP 07.93 × 10−1990.5795070574625420.8820.541.90 × 10−194
TMEM106C 02.65 × 10−1990.5554923753819840.7710.3976.35 × 10−194
CDKN3 03.21 × 10−1980.647344395853740.7150.2847.69 × 10−194
VRK1 04.26 × 10−1970.3804988373126310.5380.1671.02 × 10−192
USP1 03.68 × 10−1960.4872310521091890.6820.2848.82 × 10−192
PKMYT1 02.42 × 10−1950.3226950469252140.3860.0765.79 × 10−191
CIT 02.76 × 10−1940.362278760187630.4120.0916.61 × 10−190
TCF19 03.14 × 10−1940.3268122355230650.3920.0817.51 × 10−190
PLK1 05.72 × 10−1930.4785664050866080.4870.1361.37 × 10−188
DBF4 07.76 × 10−1930.4762433256919380.5790.2051.86 × 10−189
MCM5 04.10 × 10−1880.3897976231805050.5080.1519.83 × 10−184
EMP2 05.79 × 10−1880.4825735811885070.7290.3281.39 × 10−183
CCNB2 09.87 × 10−1870.4839902928447580.6040.2052.36 × 10−182
FOXM1 01.36 × 10−1850.3474339505745510.4830.1323.25 × 10−181
CDKN2C 05.29 × 10−1850.3907404132570060.5240.1651.27 × 10−180
CENPP 01.73 × 10−1840.4183387695299160.5210.1644.14 × 10−180
KNSTRN 02.07 × 10−1830.5202804645412160.6060.2344.96 × 10−179
PRIM2 04.38 × 10−1830.4993962872326640.7020.3291.05 × 10−178
CIP2A 01.15 × 10−1820.3388274397030430.4440.1152.76 × 10−179
C21orf58 03.86 × 10−1830.3096799682289610.3970.0899.25 × 10−178
GAS2L3 03.93 × 10−1820.3555612540430550.3830.0839.42 × 10−178
CDC20 04.93 × 10−1810.5247299164238150.6260.2211.18 × 10−175
RPA3 03.54 × 10−1790.5087840051865090.8490.5188.47 × 10−175
PSIP1 04.21 × 10−1780.5318445601598370.8580.5251.01 × 10−173
CBX5 03.40 × 10−1760.5263712782300420.8490.5228.15 × 10−173
MIS18BP1 04.87 × 10−1750.4836231633992670.6820.3161.17 × 10−171
CCNB1 08.93 × 10−1740.6282539817018280.6910.2952.14 × 10−169
DHFR 09.04 × 10−1740.4264686519287340.6350.2582.17 × 10−169
EZH2 07.76 × 10−1730.3176406814305930.4070.0991.86 × 10−168
NCAPD3 04.50 × 10−1710.3600000134374140.5180.1711.08 × 10−167
CDC6 05.25 × 10−1710.303064267396380.3430.0671.26 × 10−166
FAM111A 01.10 × 10−1690.3919902225755510.510.1722.63 × 10−165
CDCA4 02.26 × 10−1670.3709463022108050.4840.1545.41 × 10−163
MIR924HG 05.76 × 10−1660.3216765264180050.2860.0431.38 × 10−161
BUB3 01.56 × 10−1650.5758249127845370.8490.5753.74 × 10−161
CENPQ 05.28 × 10−1650.331976799274660.4560.1331.27 × 10−161
CDKN2D 01.41 × 10−1560.5709058009680530.6640.3353.37 × 10−152
CHAF1A 07.21 × 10−1560.314414456492640.4120.1131.73 × 10−151
SAC3D1 01.94 × 10−1550.4734181334748990.7020.3624.65 × 10−151
NAV2 04.38 × 10−1550.6856373224755290.8840.6631.05 × 10−150
POLD3 02.41 × 10−1530.4036820028905450.5590.2185.76 × 10−149
HIST1H1A 05.94 × 10−1530.4690007003249170.3110.0621.42 × 10−148
CCDC34 05.20 × 10−1510.4409472015767890.6890.3421.24 × 10−146
LRR1 02.48 × 10−1500.3722929871673170.6210.2675.95 × 10−146
ECT2 02.06 × 10−1460.3690354532806010.560.2214.92 × 10−142
RAD21 08.57 × 10−1440.4951445927868760.8040.5082.05 × 10−139
PARP1 04.44 × 10−1390.4060654236378360.6490.3061.06 × 10−134
TUBG1 06.03 × 10−1390.4333342551011580.7780.4591.45 × 10−134
FOSL1 04.94 × 10−1370.4912505108269170.7780.4851.18 × 10−133
SRSF2 05.02 × 10−1380.467241984690590.9120.6811.20 × 10−132
EXOSC8 01.27 × 10−1360.4155361953345730.7270.4013.05 × 10−132
RFC4 02.50 × 10−1360.3581480032098050.5410.2185.98 × 10−134
CMC2 01.98 × 10−1290.4536581479526040.8530.6064.74 × 10−125
TRIM59 06.80 × 10−1280.3698535012936690.4970.1951.63 × 10−123
NCEH1 09.76 × 10−1260.3659132857249980.5180.2122.34 × 10−121
MCM3 02.65 × 10−1250.3758613629780720.5180.2146.34 × 10−121
SMC1A 08.46 × 10−1250.4273721907933450.750.442.03 × 10−120
TEX30 02.02 × 10−1240.3707361409701490.6190.2954.84 × 10−120
NUDT1 09.64 × 10−1230.3938535929488460.7410.4192.31 × 10−118
CSE1L 01.75 × 10−1210.3346898159784670.6150.2884.19 × 10−117
SCLT1 05.47 × 10−1210.4598457973398580.6680.3591.31 × 10−116
ALYREF 08.72 × 10−1210.4028622380773450.7790.4932.09 × 10−115
HAT1 09.02 × 10−1180.387737257260550.7340.4222.16 × 10−113
SMC3 06.38 × 10−1160.4366890458243740.8360.5791.53 × 10−111
KIRREL3 01.41 × 10−1140.4525775932794480.6620.3573.37 × 10−110
BCL2L12 03.60 × 10−1140.3329160749523970.5610.2548.62 × 10−110
GPSM2 04.01 × 10−1140.3228070741832210.4820.1949.59 × 10−109
RAB3B 02.04 × 10−1120.4193722698088720.8070.4964.88 × 10−108
CDC25B 04.30 × 10−1110.3353449212438390.4770.1931.03 × 10−106
WDR34 01.19 × 10−1100.3208153794731830.5870.2722.85 × 10−106
RFX8 06.64 × 10−1070.3284031381052450.40.1421.59 × 10−102
G2E3 05.74 × 10−1060.3738885322321320.5780.2841.37 × 10−101
CKAP5 09.76 × 10−1060.3891442625183080.6920.3972.34 × 10−101
EXOSC9 04.42 × 10−1050.3355870337721450.6340.3251.06 × 10−99
EZR 02.08 × 10−1000.37491206996910.6850.3854.99 × 10−97
ANP32E 01.16 × 10−990.4238057846667550.770.5142.79 × 10−95
KIF22 01.84 × 10−990.3890352855748240.7180.434.41 × 10−95
FUS 01.36 × 10−980.3906429723272490.8910.6913.26 × 10−93
RBMX 03.48 × 10−970.3800132517981350.8460.6118.33 × 10−93
HSPB11 05.70 × 10−970.3755825855604170.8780.6481.37 × 10−93
PLAU 02.59 × 10−950.4844380897914650.5360.2616.20 × 10−90
CCDC14 02.89 × 10−940.3130338193002790.5490.2676.92 × 10−90
ACYP1 04.27 × 10−940.3172642389789130.6180.3271.02 × 10−89
BTG3 05.53 × 10−940.4122835573074530.8240.5761.33 × 10−89
HMGB3 02.40 × 10−920.3324379579340130.5880.2975.76 × 10−88
ARHGAP29 01.91 × 10−910.3310870350352930.4650.2034.57 × 10−87
PGP 05.01 × 10−910.3637452805920720.8630.6421.20 × 10−86
POP7 05.29 × 10−840.350411009761860.8240.5951.27 × 10−79
MOK 03.21 × 10−830.467375135199660.6340.387.69 × 10−79
CBX1 06.14 × 10−830.3527018855833830.8440.6291.47 × 10−75
FABP5 01.85 × 10−780.3061179254137340.5820.3084.43 × 10−74
SAP30 08.53 × 10−770.3526355217350670.7430.5042.04 × 10−72
MAP3K20 02.57 × 10−740.336407020909460.7890.5456.15 × 10−70
HIST1H1E 03.63 × 10−730.3393064088691520.3670.1578.69 × 10−69
LSM2 02.41 × 10−700.318405623335330.830.6065.77 × 10−66
PBX3 03.22 × 10−690.3700319250132180.7210.4887.72 × 10−65
HYI 04.02 × 10−680.3203732540264470.7870.559.63 × 10−64
WNT5B 03.78 × 10−660.3183563999853770.60.3489.06 × 10−62
CRIM1 09.71 × 10−650.3664419196303050.820.6012.33 × 10−61
FAF1 04.79 × 10−630.3265950805170330.7570.5171.15 × 10−59
RBBP7 04.80 × 10−630.3120268485378510.7610.5351.15 × 10−58
CCDC88A 02.20 × 10−620.3262906777534680.7590.5365.27 × 10−58
HAS2 06.61 × 10−540.3487879085293690.7650.5131.58 × 10−49
C11orf96 26.44 × 10−1040.7408669648746050.7540.5151.54 × 10−99
PTTG1 301.688181514640340.9840.5790
CDKN3 301.322801700530980.9280.3450
BIRC5 301.244482941355780.9690.3470
CCNB1 31.68 × 10−2701.539891204336470.8890.3514.02 × 10−266
CDC20 35.47 × 10−2351.193855934524490.8060.2811.31 × 10−230
PRC1 31.56 × 10−2251.031315009770580.890.3433.73 × 10−221
CCNB2 38.32 × 10−2060.895055391937410.7720.2661.99 × 10−201
CENPW 31.90 × 10−1960.9067486259899080.9180.4294.55 × 10−192
CENPF 31.65 × 10−1911.109465349060020.9490.3823.95 × 10−187
DLGAP5 32.36 × 10−1820.8283276189512420.7550.2585.66 × 10−178
STMN1 31.16 × 10−1721.048543500492140.9930.6232.79 × 10−168
KIF20A 36.24 × 10−1530.4781119137348250.4570.1091.49 × 10−148
PBK 36.93 × 10−1530.7680874594090720.8170.3171.66 × 10−148
TROAP 33.95 × 10−1430.5350245177980470.5750.1839.45 × 10−139
CKS1B 31.16 × 10−1410.7492098860228390.9320.5352.79 × 10−137
CDCA3 39.83 × 10−1390.6555163715269580.6960.2562.35 × 10−134
HMGB3 32.65 × 10−1340.6861787654950080.7330.3386.34 × 10−130
CEP55 32.18 × 10−1290.7127815911352840.7020.2815.23 × 10−125
PHF19 38.56 × 10−1240.6267041477540390.7550.3452.05 × 10−119
ANLN 31.05 × 10−1230.6208713308212750.7510.32.52 × 10−119
SNHG3 32.41 × 10−1220.6146036658129250.620.2645.77 × 10−118
ARL6IP1 33.38 × 10−1190.9523336401241790.8990.6518.10 × 10−116
DTYMK 32.31 × 10−1170.6775274256015350.940.6575.54 × 10−113
LSM5 35.07 × 10−1140.6240234361441640.9410.7241.21 × 10−109
PCLAF 31.06 × 10−1100.6345443354056420.8780.422.53 × 10−107
DEPDC1 31.15 × 10−1090.6380993702536510.6110.2392.76 × 10−104
MAD2L1 31.21 × 10−1040.5989645479562720.7230.3382.91 × 10−100
TPX2 31.75 × 10−1020.7191876030109110.7720.3714.19 × 10−98
PRR11 31.43 × 10−960.4895485301508620.5980.243.42 × 10−92
MKI67 32.35 × 10−960.5969100078840260.7530.3125.62 × 10−92
DDX39A 33.47 × 10−960.6022135775932470.8080.5168.30 × 10−92
PIMREG 37.42 × 10−920.3997787253458630.4330.1391.78 × 10−87
SKA2 31.39 × 10−890.5547644568293790.840.5343.33 × 10−85
CKAP2 39.51 × 10−880.8447080422035150.7310.4042.28 × 10−84
CENPN 37.43 × 10−870.4855814700625750.6790.3341.78 × 10−82
CENPM 36.78 × 10−860.4967531626302720.6510.3031.62 × 10−81
TK1 33.41 × 10−800.4895491058778910.7290.368.16 × 10−76
SMC4 34.70 × 10−800.6252040412901380.8670.5221.12 × 10−75
NUSAP1 31.54 × 10−770.4236438969356890.7990.3533.68 × 10−73
HMMR 39.63 × 10−770.58585485445980.6060.2682.31 × 10−72
TACC3 38.69 × 10−750.4888473210715640.6720.312.08 × 10−70
ASPM 33.16 × 10−730.5878595711280480.6350.2927.57 × 10−68
ANP32E 33.27 × 10−670.5205324901045680.8180.5617.83 × 10−63
KIF20B 37.51 × 10−660.5663914019954410.6580.3291.80 × 10−61
RPL39L 31.40 × 10−630.4494334266652340.7290.4123.36 × 10−59
HOTAIRM1 39.20 × 10−620.5395380615742980.7220.4862.20 × 10−56
NASP 31.66 × 10−580.4813507083198280.8570.6153.98 × 10−54
EMP2 37.00 × 10−550.4373254917809740.7030.4161.68 × 10−50
SNHG19 34.24 × 10−530.3561763678158280.420.1841.02 × 10−48
MZT1 32.55 × 10−520.452520677024740.6720.4256.12 × 10−48
PLK1 35.14 × 10−520.3631574327672630.480.2111.23 × 10−47
NEK2 33.87 × 10−480.3030089728606810.3490.1349.28 × 10−44
KPNA2 34.96 × 10−450.4082244764019820.8550.6231.19 × 10−40
CENPE 39.27 × 10−450.4299633956684570.5890.3032.22 × 10−40
NOP58 31.29 × 10−430.3984972635914030.70.4823.08 × 10−40
CENPH 35.09 × 10−430.3429771265213250.5620.3091.22 × 10−38
RUVBL2 34.62 × 10−430.4019381427082550.6430.4281.11 × 10−37
TYMS 31.75 × 10−410.3482455823866490.7740.4424.20 × 10−37
NUDT1 31.27 × 10−400.3872424641098050.7120.493.03 × 10−35
KNSTRN 34.48 × 10−390.4192950751177130.5570.3191.07 × 10−35
SMC2 31.60 × 10−380.3637845686866390.7470.5083.82 × 10−33
SNRPA 34.23 × 10−360.379278648857330.5840.3751.01 × 10−31
DNMT1 32.02 × 10−360.3947157138629480.7850.5644.84 × 10−31
NUF2 38.63 × 10−300.3216693557083390.4930.2622.07 × 10−25
EZR 36.54 × 10−280.3382040743066780.6650.4511.57 × 10−23
NDC80 31.26 × 10−270.3198252385799570.480.263.01 × 10−23
SGO2 35.73 × 10−250.3925845393382030.5450.3311.37 × 10−20
Table 4

Highly variable genes after cell cycle regression in CAFs isolated from Patient3.

GeneClusterp-ValueAverage log2FC Pct.1Pct.2p-Value Adjusted
GDF15 01.00 × 10−1240.6700122369810090.5170.2382.33 × 10−119
CEMIP 04.81 × 10−1150.7901929191945190.6210.3471.12 × 10−110
DEPTOR 05.87 × 10−1060.3540827306706040.3790.1391.36 × 10−101
MXD4 06.26 × 10−900.3935807128191880.6420.3791.45 × 10−85
ARMC9 09.84 × 10−810.4530919704570530.6760.4382.28 × 10−77
PNRC1 02.58 × 10−770.317181718453080.4480.2165.98 × 10−74
CACNB4 02.37 × 10−740.4348803393859220.5430.3045.50 × 10−69
PLXDC2 07.28 × 10−680.3038632516589210.4270.2091.69 × 10−62
KIF26B 01.29 × 10−560.4663855788655740.5890.3762.98 × 10−52
ANKRD37 02.18 × 10−560.5025295234751670.4820.2795.05 × 10−52
FAM43A 06.47 × 10−570.3414959457686160.4690.2571.50 × 10−51
TOP2A 101.727048015684970.8620.3450
UBE2C 101.334973068325520.7330.2170
HMGB2 101.310686785262620.9110.3990
HIST1H1B 101.210113441825680.6140.1020
CDK1 101.208996493463280.7370.130
MKI67 101.034319811853350.810.3530
DIAPH3 101.000414868140250.9450.60
CDCA8 100.7797022400862650.5950.120
HJURP 100.7654594936664790.5730.0820
CDCA2 100.7022743597482420.5650.1210
GTSE1 100.6937613362635620.6040.160
NCAPG 100.6598185055878770.6270.1720
AURKB 100.6191165210958210.5390.1080
FBXO5 100.6153894814825150.5250.1030
CKAP2L 100.5987920063147650.5410.1030
ARHGAP11B 100.58124173458360.4730.0740
KIF18B 100.5801428797524720.4710.0710
KIF23 12.27 × 10−2870.7206389598005980.6910.2355.27 × 10−283
HIST1H1A 16.01 × 10−2850.9136098007016360.4810.1061.39 × 10−280
SMC4 17.58 × 10−2830.8649794220511720.90.5141.76 × 10−278
ESCO2 12.48 × 10−2810.5023658365338970.4580.0845.75 × 10−277
APOLD1 14.64 × 10−2790.8383686402543380.670.2371.07 × 10−274
KIF2C 17.56 × 10−2780.5897877367526980.490.1041.75 × 10−273
MELK 13.52 × 10−2740.5757367394672580.5830.168.15 × 10−270
TMPO 14.30 × 10−2740.7679470924804340.8430.4239.96 × 10−270
CLSPN 16.95 × 10−2740.7198763688000880.7430.2751.61 × 10−269
TACC3 11.79 × 10−2700.7484583804641730.7170.2634.16 × 10−266
LINC01572 11.38 × 10−2680.5899352308821030.5270.1343.20 × 10−263
NEIL3 14.34 × 10−2660.4370980812589120.3920.0611.01 × 10−261
BRIP1 16.60 × 10−2640.6377129167897260.5880.1691.53 × 10−259
KIF20B 12.62 × 10−2590.7264637011305490.6990.2586.08 × 10−255
CEP128 13.30 × 10−2590.5508228822092330.4950.1187.64 × 10−255
ASPM 15.17 × 10−2520.8208695813215950.6880.2511.20 × 10−247
KNL1 19.01 × 10−2490.5953584141265820.6070.1842.09 × 10−244
KIF11 14.17 × 10−2480.6071818452383620.5910.189.66 × 10−244
KIFC1 15.13 × 10−2460.4851675340713160.4760.1081.19 × 10−241
NDC80 15.91 × 10−2450.5815458687914170.5790.1671.37 × 10−240
CENPE 11.74 × 10−2420.8304867614280120.6650.2454.03 × 10−238
NUF2 16.57 × 10−2420.6380103956897060.6120.1971.52 × 10−238
CENPU 14.52 × 10−2400.5815986097716160.6980.2521.05 × 10−235
TTK 17.67 × 10−2380.4375924631551190.4050.0761.78 × 10−233
MIR924HG 11.21 × 10−2380.6477013795857970.5160.1382.81 × 10−233
DBF4 17.15 × 10−2370.6324647853819520.6530.2421.66 × 10−232
CENPK 11.91 × 10−2330.620442315641810.7180.2924.42 × 10−229
SGO2 12.05 × 10−2320.6671207089297060.6450.2294.75 × 10−228
CCNA2 11.22 × 10−2310.6237789741170520.6310.2162.84 × 10−228
ATAD2 13.59 × 10−2290.6587675653390010.7210.2978.32 × 10−225
ORC6 12.23 × 10−2270.4817849259370810.520.1415.18 × 10−223
SPC25 11.19 × 10−2250.5818335844320110.5920.1912.75 × 10−221
KIF14 12.21 × 10−2240.4904966907091610.4590.1095.11 × 10−220
UBE2T 14.57 × 10−2240.6213130857752680.7330.3131.06 × 10−219
HIST1H1E 13.81 × 10−2170.7222668885414420.5270.1758.82 × 10−213
KIF4A 16.36 × 10−2160.5438759548677820.560.1751.47 × 10−212
GMNN 11.53 × 10−2150.5839982645235950.7360.3173.54 × 10−211
FEN1 12.71 × 10−2130.5073802191991320.5830.196.29 × 10−209
NUSAP1 12.89 × 10−2120.7729363966067030.7630.3716.70 × 10−208
CKS2 13.74 × 10−2120.8710138746670810.8830.6098.66 × 10−208
NSD2 11.62 × 10−2110.6307846675559470.7480.363.77 × 10−207
AURKA 15.76 × 10−2100.7340783915298510.5820.2031.34 × 10−205
CENPF 14.08 × 10−2120.9814932665529530.8360.469.46 × 10−205
ANLN 15.04 × 10−2080.6655801611601350.710.3051.17 × 10−203
CCDC18 12.17 × 10−2050.5379926312300340.5890.2095.03 × 10−201
SGO1 12.14 × 10−2040.424621400867290.4450.1094.95 × 10−200
BARD1 11.55 × 10−2040.4696754157890940.510.1523.60 × 10−199
DLEU2 19.72 × 10−2020.6003259143952490.6810.2972.25 × 10−197
HIST1H3B 18.08 × 10−1980.3313645148601510.2810.0371.87 × 10−193
KIF15 13.79 × 10−1970.3669877271625540.3670.0748.79 × 10−193
TPX2 13.06 × 10−1930.7321272371682980.8310.4587.09 × 10−189
KIF18A 13.14 × 10−1920.5104341902404870.5350.1787.28 × 10−188
SPDL1 15.37 × 10−1910.6390041452247190.8050.4741.24 × 10−186
PBK 16.00 × 10−1880.6526097380452310.7740.3751.39 × 10−183
BUB1B 16.41 × 10−1860.4473664779323450.4940.1461.49 × 10−181
RFC3 16.72 × 10−1850.4420170477286230.5010.1541.56 × 10−180
ARHGAP11A 12.57 × 10−1840.448338512873110.4270.1145.96 × 10−180
CDC25C 18.49 × 10−1840.3026662701994180.2740.0381.97 × 10−179
USP1 19.57 × 10−1840.5540366411649410.7160.3392.22 × 10−179
H2AFX 13.44 × 10−1830.6205294413436850.7120.3597.98 × 10−179
CDCA4 11.80 × 10−1830.4211678601410020.4690.1414.16 × 10−178
RRM2 17.34 × 10−1820.57140473988390.6590.2761.70 × 10−177
POLQ 11.14 × 10−1810.3348813547436590.3380.0672.65 × 10−176
BRCA1 11.27 × 10−1790.4638825434055120.5330.182.94 × 10−176
C21orf58 13.34 × 10−1740.3496296624155530.3660.0847.74 × 10−170
CENPA 13.60 × 10−1730.5018651114813930.4540.1398.36 × 10−170
CIT 17.99 × 10−1730.4143582334647050.4230.1171.85 × 10−168
RAD51AP1 12.60 × 10−1720.3938857178178820.4170.1116.02 × 10−168
KPNA2 18.94 × 10−1710.8522694718990630.8580.5932.07 × 10−166
GAS2L3 12.47 × 10−1690.4251235167895110.3760.0945.72 × 10−165
FAM83D 11.28 × 10−1660.3555322712969980.3250.0682.96 × 10−162
DNAJC9 19.66 × 10−1660.5390874263766570.80.4582.24 × 10−161
MIS18BP1 12.18 × 10−1630.5265475605320240.6720.3215.06 × 10−159
TYMS 16.28 × 10−1630.5670801739399060.8460.5081.46 × 10−158
CKAP2 13.26 × 10−1620.6956637227237630.7090.3617.56 × 10−158
NCAPH 18.18 × 10−1620.3102717699136980.3380.0741.90 × 10−157
BRCA2 11.09 × 10−1610.4137296932258560.4440.1362.53 × 10−157
FAM111A 12.02 × 10−1610.3995595334112840.4390.1354.69 × 10−158
ECT2 11.61 × 10−1600.4778563741385880.5620.2183.74 × 10−156
HMMR 11.47 × 10−1500.5511721654665930.6370.2753.41 × 10−146
MAD2L1 11.96 × 10−1490.4517992590930440.6380.2724.55 × 10−145
SHCBP1 13.08 × 10−1470.4238567191817290.5360.2017.13 × 10−144
HIST1H1C 11.37 × 10−1450.6089272357095920.5590.2553.18 × 10−141
MXD3 17.58 × 10−1430.389861072395680.3870.1141.76 × 10−138
DNMT1 11.44 × 10−1420.5155505693490730.90.663.34 × 10−138
NAV2 13.85 × 10−1420.6880919844444010.7760.5128.92 × 10−138
CDC45 16.33 × 10−1410.3104358088018020.3660.0981.47 × 10−136
PIF1 15.35 × 10−1390.360168341617810.2920.0671.24 × 10−134
MYBL1 11.80 × 10−1360.3183183342418420.3470.0934.17 × 10−132
VRK1 15.73 × 10−1360.3921390406308860.5020.191.33 × 10−131
ZWINT 16.04 × 10−1370.4513029353978520.610.2771.40 × 10−131
DTL 13.02 × 10−1350.3670723273963110.3720.1087.00 × 10−131
SMC2 14.91 × 10−1330.492540048976090.8020.4891.14 × 10−128
HELLS 14.44 × 10−1310.4724911973821940.5970.2691.03 × 10−126
SCLT1 15.28 × 10−1310.5500061553687930.6770.3771.22 × 10−126
CEP55 11.14 × 10−1300.4908799474946920.6840.3332.64 × 10−126
MND1 18.76 × 10−1300.3123016439255590.3610.1032.03 × 10−125
SKA3 14.05 × 10−1270.3104328165367860.3540.1029.39 × 10−123
MCM7 13.48 × 10−1250.436945309737090.6620.3178.07 × 10−121
FOSL1 11.48 × 10−1250.5790875518573560.8380.6143.44 × 10−120
RAD18 16.07 × 10−1240.3690910893714990.4930.1941.41 × 10−119
EZH2 12.68 × 10−1220.3500870934154130.430.1516.21 × 10−118
SPATA5 14.54 × 10−1210.4303338801677290.5390.2451.05 × 10−116
MIS18A 15.92 × 10−1200.3386273472952940.4550.1671.37 × 10−116
NCAPG2 18.08 × 10−1200.3889535979802890.5180.2121.87 × 10−115
HIST2H2AC 12.18 × 10−1170.4598270841177360.4470.1815.04 × 10−113
CIP2A 12.48 × 10−1180.3485892584634760.4430.1645.75 × 10−113
NCAPD3 14.68 × 10−1180.3644290298678630.4980.2051.08 × 10−112
PCLAF 13.77 × 10−1160.4581376961756640.8620.5848.74 × 10−112
CENPP 16.27 × 10−1160.4154199819232840.5060.2121.45 × 10−111
DEPDC1 11.61 × 10−1130.3938126939133510.5160.2113.72 × 10−109
PRIM2 14.97 × 10−1130.4228738879177860.6920.3721.15 × 10−112
RRM1 18.12 × 10−1130.4319606477469610.6650.3551.88 × 10−108
G2E3 11.51 × 10−1120.4447859778263410.5850.2963.50 × 10−108
PCNA 13.48 × 10−1120.4769485831427260.6610.3698.06 × 10−108
AP001347.1 11.12 × 10−1110.3158129488360760.3730.1252.60 × 10−107
CKS1B 13.12 × 10−1090.4565822585640460.7780.4797.24 × 10−105
GPSM2 11.17 × 10−1080.3457289432593480.4170.1562.72 × 10−105
PRC1 12.53 × 10−1070.4769530717810390.7830.4495.87 × 10−103
KNSTRN 19.23 × 10−1070.4014612591058150.5120.2252.14 × 10−102
RACGAP1 11.35 × 10−1060.3327368478778240.4110.153.13 × 10−103
PLK1 12.35 × 10−1060.4126736181860310.460.1845.44 × 10−102
FANCI 13.69 × 10−1070.3241345691420210.4330.1648.55 × 10−102
ITGB3BP 19.35 × 10−1050.362777176256360.5960.2872.17 × 10−100
POLD3 11.37 × 10−1030.3486185444287780.4610.1893.17 × 10−99
DTYMK 12.55 × 10−1030.4327054045527040.9020.6925.91 × 10−99
TRIM59 12.03 × 10−980.385705442173490.5090.2374.70 × 10−94
RFC4 11.74 × 10−970.3537963353743520.4890.2154.03 × 10−93
CHAF1A 18.15 × 10−970.3104891964404830.4090.1561.89 × 10−92
MCM5 11.35 × 10−960.345538379299170.5360.2413.14 × 10−92
GINS2 17.46 × 10−950.347195635164370.5180.2331.73 × 10−91
CDKN2D 12.50 × 10−940.3683250344418990.3910.1555.79 × 10−90
PGP 11.02 × 10−930.4078351806956080.7980.5442.37 × 10−89
SMC3 14.64 × 10−910.4088445005439070.8360.621.08 × 10−86
NASP 15.28 × 10−840.3954023769755930.8470.6111.22 × 10−80
CKAP5 11.46 × 10−830.4104913528534660.670.4193.39 × 10−78
CBX5 12.20 × 10−820.3695181828590710.8640.6525.10 × 10−78
CCDC14 12.74 × 10−810.3088551465671340.4550.2076.35 × 10−77
SMC1A 11.81 × 10−780.3763375267935470.6550.3894.20 × 10−74
CENPM 11.94 × 10−770.3297451498191190.5970.3164.50 × 10−73
BUB3 13.08 × 10−760.4012930684946840.7970.5867.15 × 10−73
PRR11 19.66 × 10−760.3566964185451980.5420.282.24 × 10−71
SAP30 11.49 × 10−750.3409837275798720.5550.2963.45 × 10−71
SAC3D1 12.96 × 10−740.3455887256446880.5880.3336.87 × 10−71
DHFR 11.98 × 10−720.3098444639623290.5130.2564.60 × 10−68
EMP2 15.47 × 10−720.3081389704607420.5370.2751.27 × 10−67
CMC2 12.34 × 10−700.3415316177530680.7250.4795.42 × 10−66
POLE3 11.23 × 10−670.3066321370121190.5860.3272.85 × 10−64
BIRC5 14.30 × 10−660.3646360437351490.8270.5729.97 × 10−62
PSIP1 14.97 × 10−660.3355704004128720.8140.5911.15 × 10−61
CDK5RAP2 12.04 × 10−610.3038975109509780.5330.2934.74 × 10−57
PARP1 14.80 × 10−610.3375617775737470.7490.5291.11 × 10−56
LCORL 15.83 × 10−610.3297130811813350.4890.2681.35 × 10−56
BTG3 11.85 × 10−600.3323371337554570.7170.4774.28 × 10−56
TK1 12.04 × 10−590.335101818799420.8070.594.72 × 10−55
RAD51B 12.52 × 10−580.3310805830173550.5660.3355.84 × 10−54
CENPW 12.58 × 10−540.3089986072779120.8630.6295.97 × 10−50
CDC20 15.43 × 10−520.3182954842471530.6420.3821.26 × 10−47
EXOSC9 16.81 × 10−540.3040121960322690.5850.3641.58 × 10−46
KMT5A 12.58 × 10−500.3061851770054780.5970.3785.98 × 10−46
RAD21 13.48 × 10−500.3199479579481110.7150.5038.07 × 10−46
NCEH1 17.36 × 10−490.3107933069039880.5580.3441.71 × 10−44
CCNB1 201.311539135910010.9240.4230
CDC20 201.121293110517830.8670.3480
CENPF 201.040266778519460.9560.4610
PTTG1 201.030547113797230.9840.70
DLGAP5 200.9177546457542220.7530.2680
CCNB2 21.58 × 10−2490.8251031716570370.7260.3013.67 × 10−246
PRC1 23.33 × 10−2440.8712409435575880.8660.4557.71 × 10−239
TPX2 24.54 × 10−2350.8767802108881090.8880.4741.05 × 10−231
CDKN3 25.29 × 10−2330.8653240996020130.9020.5531.23 × 10−228
BIRC5 22.76 × 10−2110.7950523175087020.9080.5726.40 × 10−206
PBK 21.49 × 10−2040.7876611103946090.8190.3953.45 × 10−200
ARL6IP1 26.80 × 10−1950.8168667738747490.8140.4941.58 × 10−190
HMMR 21.85 × 10−1830.7154329145535750.6850.2924.29 × 10−179
CEP55 21.66 × 10−1750.7045104011831170.7270.353.86 × 10−171
MKI67 22.89 × 10−1600.6445842026422530.8120.3886.70 × 10−156
NUSAP1 22.03 × 10−1500.6484344467266030.7780.3984.70 × 10−146
CDCA3 21.88 × 10−1380.5893700382119540.5680.2524.36 × 10−134
SMC4 22.00 × 10−1310.6084598780885310.8690.5514.64 × 10−128
CKAP2 24.48 × 10−1170.6800978274576230.6940.3921.04 × 10−112
CKS1B 22.31 × 10−1080.5597757888187620.770.5045.35 × 10−104
PHF19 22.70 × 10−1030.539269751217950.7010.4556.27 × 10−98
DEPDC1 22.72 × 10−990.5176136842986510.5050.2386.30 × 10−95
HMGB3 27.45 × 10−900.5220624168877590.7220.5131.73 × 10−86
KPNA2 21.33 × 10−880.4420588241587830.8310.623.07 × 10−83
SNHG3 24.26 × 10−850.5159308864297530.550.3399.87 × 10−81
ANLN 21.74 × 10−770.4552106594524470.6250.3574.04 × 10−72
PLK1 29.38 × 10−720.4228913218824430.4440.212.17 × 10−67
MAD2L1 22.06 × 10−710.4681849874784440.550.3224.78 × 10−67
TACC3 29.49 × 10−700.4258328176673130.590.3292.20 × 10−64
CENPE 28.03 × 10−670.4336531077996180.5630.3021.86 × 10−62
ASPM 22.51 × 10−620.4650872111150130.5580.3175.83 × 10−58
KIF20B 27.25 × 10−440.3590354391339110.5420.331.68 × 10−40
PTTG1 31.81 × 10−580.4594138515060370.930.7244.19 × 10−54
Table 5

Shared highly variable genes identified from CAFs/DAFs isolated from chronic pancreatitis and pancreatic cancer patients.

ANLN, APOLD1, ARHGAP11A, ARH11B, ASPM, ATAD2, AURKA, AURKB, BARD1, BIRC5, BRCA1, BRCA2, BRIP1, BUB1B, C21orf58, CCDC14, CCDC18, CCNA2, CCNB1, CCNB2, CDC20, CDC45, CDCA2, CDCA3, CDCA4, CDCA8, CDKN2D, CDKN3, CENPA, CENPE, CENPF, CENPK, CENPM, CENPP, CENPU, CEP128, CEP55, CIP2A, CIT, CKAP2, CKAP2L, CLSPN, DBF4, DEPDC1, DHFR, DLEU2, DLGAP5, DNAJC9, ECT2, EMP2, ESCO2, EZH2, FAM111A, FANCI, FBXO5, FEN1, G2E3, GAS2L3, GINS2, GMNN, GPSM2, GTSE1, H2AFX, HELLS, HIST1H1A, HIST1H1B, HIST1H1E, HJURP, HMGB2, HMMR, KIF11, KIF14, KIF18A, KIF18B, KIF20B, KIF23, KIF2C, KIF4A, KIFC1, KNL1, KNSTRN, LINC01572, MAD2L1, MCM7, MELK, MIR924HG, MIS18BP1, MKI67, MND1, MXD3, MYBL1, NAV2, NCAPG, NCAPG2, NCAPH, NDC80, NEIL3, NSD2, NUF2, NUSAP1, ORC6, PBK, PCLAF, PHF19, PLK1, POLD3, PRC1, PRIM2, PRR11, RACGAP1, RAD51AP1, RFC3, RRM1, RRM2, SACD1, SAP30, SCLT1, SGO1, SGO2, SHCBP1, SMC1A, SMC2, SMC4, SPC25, TACC3, TMPO, TOP2A, TPX2, TRIM59, TTK, UBE2C, UBE2T, USP1, VRK1, ZWINT

3.3. Instead of myCAF-, iCAF-, or apCAF-Specific Clusters, Rather a myCAF-Like Subtype with CXCL12 Expression Observed in Primary Isolated Disease-Associated Fibroblasts

We next analyzed potential myCAF, iCAF or apCAF transcriptomes in our primary disease-associated fibroblasts from pancreatic cancer and chronic pancreatitis patients. We used myCAF, iCAF, and apCAF markers as previously described [10,11] (see Table 6). As shown in Figure 7, we did not detect any myCAF-, iCAF-, or apCAF-specific cluster in disease-associated fibroblasts from pancreatic cancer or chronic pancreatitis patients. Yet, all disease-associated fibroblasts showed a gene expression profile similar to the myCAFs described by Öhlund et al. (Figure 7A). We observed positive staining of αSMA in all cases, we also observed positive expression of CXCL12, an iCAF marker (Figure 8).
Table 6

Lists of selected markers for myCAF, iCAF, and apCAF.

CAF SubtypeSelected Markers
myCAF (Öhlund et al.) [10] Acta2, Vim, Ctgf, Col1a1, Col5a1, Col6a1
myCAF (Elyada et al.) [11] Tnc, Tgfb1, Thy1, Tagln, Col12a1, Pdgfrb
iCAF (Öhlund et al.) [10] Il1, Il6, Il11, Lif
iCAF (Elyada et al.) [11] Clec3b, Col14a1, Gsn, Ly6c1, Cxcl12
apCAF (Elyada et al.) [11] Slpi, Saa3, Cd74, H2-Ab1, NKain4, Irf5
Figure 7

No myofibroblastic, inflammatory or antigen-presenting cancer-associated fibroblast-specific cluster, but exhibit myCAF-like profiling in disease-associated fibroblasts from pancreatic cancer and chronic pancreatitis patients. Cell with (A,B) myofibroblastic, (C,D) inflammatory, and (E) antigen-presenting cancer-associated fibroblasts are visualized in fibroblasts from pancreatic cancer and chronic pancreatitis patients. Lists of selected markers are listed Table 5, markers were selected from the publications Öhlund et al. [10] for (A,C), Elyada et al. [11] for (B,D,E).

Figure 8

Immunocytochemistry of αSMA and CXCL12 in disease-associated fibroblasts from pancreatic cancer and chronic pancreatitis patients. Cells from (A) patient1, (B) from patient2, and (C) from patient3 for αSMA staining, (D) cells from patient1, (E) from patient2, and (F) from patient3 for CXCL12 staining. Bar: 50 μm.

In summary, our single-cell RNA sequencing and bioinformatics analysis identified several highly variable genes including IFI27, KRT18, KRT19, MMP1, MMP3, and NEFL, whose expression is associated with a shorter overall survival of pancreatic cancer patients. The majority of highly variable genes are however dependent on the cell cycle; therefore, we performed cell cycle regression analyses. We identified IGFBP3 and IGFBP5 after cell cycle regression, which may potentially contribute to CAF heterogeneity. Here, we could not identify myCAF-, iCAF-, or apCAF-specific clusters, but the expression profiling resemble a rather myCAF-like subtype. Most interestingly, after cell cycle regression, we observed large number of overlapping highly variable genes between samples from pancreatic cancer and chronic pancreatitis patients.

4. Discussion

Increasing evidence shows that CAFs represent a highly heterogeneous subpopulations that can be both tumor-promoting and tumor-suppressing, highlighting the importance of the identification and characterization of the diversity of CAF subtypes [4]. In the current study, we isolated primary disease-associated fibroblasts by the outgrowth method from pancreatic cancer and chronic pancreatitis patients. By using single-cell RNA sequencing and bioinformatics analysis, we identified several highly variable genes including IFI27, KRT18, KRT19, MMP1, MMP3, and NEFL. Expression of these genes is associated with shorter overall survival of pancreatic cancer patients (Figure 3). IFI27 has been previously identified as a prognostic marker for pancreatic cancer [18], and involved in pancreatic cancer migration and invasion [19]. The above-mentioned genes are not exclusively expressed in CAFs/DAFs. Yet, our data support that factors expressed in CAFs/DAFs can contribute to pancreatic cancer migration, invasion, and patient outcome. We selected the outgrowth technique that has been established for isolating pancreatic CAFs and has become a common CAF isolation strategy. In our scRNAseq analysis, we found that the majority of identified highly variable genes are associated with the cell cycle. It was therefore important to conduct cell cycle regression [17], which showed that signals originating from cell cycle-associated factors have a strong impact on cluster heterogeneity (Figure 6). Interestingly, a number of highly variable features after cell cycle regression are commonly found in CAFs/DAFs isolated from chronic pancreatitis and pancreatic cancer patients (Table 5). These 135 factors still include a number of cell cycle-associated factors, but also cell cycle independent factors that are implicated in tumorigenesis. For example, KNSTRN promotes tumorigenesis and gemcitabine resistance in bladder cancer [20]. ZWINT supports pancreatic cancer proliferation [21]. Further studies are required to identify which stromal factors among these 135 genes play a key role in pancreatic cancer. It needs to be further clarified, whether pancreatic cancer-derived CAFs and chronic pancreatitis-derived DAFs have already similar profiling before isolation, or whether they become similar during culture. To that end, it is necessary in the future to establish chronic pancreatitis and pancreatic cancer mouse models with fibroblast lineage-tracing systems, to subsequently isolate CAFs/DAFs, and conduct single-cell RNA sequencing both before and after cell culture. Interestingly, our findings are consistent with the study by Barrera et al. Here, microarray experiments from DAFs isolated by the outgrowth method were performed demonstrating that pancreatic cancer- and chronic pancreatitis-derived fibroblasts share the greatest similarity [7]. One of the goals of the study was to see whether we identify previously described major CAF subtypes, myCAFs-, iCAFs-, and apCAFs. We did not observe any clear myCAFs-, iCAFs-, or apCAFs-specific clusters (Figure 7). Our data are in part consistent with a recent publication, where Grünwald et al. chose the outgrowth method and identified eleven sub-clusters from ten pancreatic cancer patients, but no clear myCAF versus iCAF subpopulation differences [22]. Initially, myCAFs and iCAF subtypes have been described by Öhlund et al. [10]. For the majority of their experiments, quiescent cells were isolated by Collagenase P and DNAse I digestion and co-cultured with pancreatic cancer organoids [10]. Murine late-stage tumors of KPC mice (Pdx1-Cre; lox-stop-lox-Kras) supported the presence of iCAFs and myCAFs, that were isolated by digesting tissue with Pronase, Collagenase P, and DNAse I [23]. Elyada et al. isolated single cells from human pancreatic cancer patients and KPC mice by digestion with Collagenase D, Liberase DL, and DNAse I [11]. Beside myCAFs and iCAFs, the study identified an additional subpopulation of CAFs expressing MHC class II and CD74 (apCAFs) [11]. Notably, in these studies enzymatic digestion methods were applied rather than the outgrowth method for CAF isolation. Whether methodological disparities have an influence on the outcome of these studies, need to be clarified in the future (e.g., via above-mentioned lineage-tracing strategies). Our study is limited by the small sample size but is the first study to conduct scRNAseq and bioinformatics analyses combined for chronic pancreatitis and pancreatic cancer patients. In summary, our scRNAseq and bioinformatics analysis identified several highly variable genes, some of whose expression is associated with shorter overall survival of pancreatic cancer patients. We could not identify myCAF-, iCAF-, or apCAF-specific clusters, but the expression profiling resemble rather a myCAF-like subtype. Most interestingly, after cell cycle regression, we observed a large number of overlapping highly variable genes between samples from pancreatic cancer and chronic pancreatitis patients, which need to be verified and functionally characterized in both pancreatic cancer and chronic pancreatitis in vivo.
  23 in total

1.  Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts.

Authors:  Mohan Bolisetty; Pasquale Laise; William F Flynn; Ela Elyada; Elise T Courtois; Richard A Burkhart; Jonathan A Teinor; Pascal Belleau; Giulia Biffi; Matthew S Lucito; Santhosh Sivajothi; Todd D Armstrong; Dannielle D Engle; Kenneth H Yu; Yuan Hao; Christopher L Wolfgang; Youngkyu Park; Jonathan Preall; Elizabeth M Jaffee; Andrea Califano; Paul Robson; David A Tuveson
Journal:  Cancer Discov       Date:  2019-06-13       Impact factor: 39.397

2.  Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15+ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy.

Authors:  Claudia X Dominguez; Sören Müller; Shilpa Keerthivasan; Hartmut Koeppen; Jeffrey Hung; Sarah Gierke; Beatrice Breart; Oded Foreman; Travis W Bainbridge; Alessandra Castiglioni; Yasin Senbabaoglu; Zora Modrusan; Yuxin Liang; Melissa R Junttila; Christiaan Klijn; Richard Bourgon; Shannon J Turley
Journal:  Cancer Discov       Date:  2019-11-07       Impact factor: 39.397

3.  Single-Nucleus and In Situ RNA-Sequencing Reveal Cell Topographies in the Human Pancreas.

Authors:  Luca Tosti; Yan Hang; Olivia Debnath; Sebastian Tiesmeyer; Timo Trefzer; Katja Steiger; Foo Wei Ten; Sören Lukassen; Simone Ballke; Anja A Kühl; Simone Spieckermann; Rita Bottino; Naveed Ishaque; Wilko Weichert; Seung K Kim; Roland Eils; Christian Conrad
Journal:  Gastroenterology       Date:  2020-11-16       Impact factor: 22.682

Review 4.  Pancreatic cancer.

Authors:  Jorg Kleeff; Murray Korc; Minoti Apte; Carlo La Vecchia; Colin D Johnson; Andrew V Biankin; Rachel E Neale; Margaret Tempero; David A Tuveson; Ralph H Hruban; John P Neoptolemos
Journal:  Nat Rev Dis Primers       Date:  2016-04-21       Impact factor: 52.329

5.  Cancer statistics, 2022.

Authors:  Rebecca L Siegel; Kimberly D Miller; Hannah E Fuchs; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2022-01-12       Impact factor: 508.702

6.  Spatially confined sub-tumor microenvironments in pancreatic cancer.

Authors:  Barbara T Grünwald; Antoine Devisme; Geoffroy Andrieux; Foram Vyas; Kazeera Aliar; Curtis W McCloskey; Andrew Macklin; Gun Ho Jang; Robert Denroche; Joan Miguel Romero; Prashant Bavi; Peter Bronsert; Faiyaz Notta; Grainne O'Kane; Julie Wilson; Jennifer Knox; Laura Tamblyn; Molly Udaskin; Nikolina Radulovich; Sandra E Fischer; Melanie Boerries; Steven Gallinger; Thomas Kislinger; Rama Khokha
Journal:  Cell       Date:  2021-10-12       Impact factor: 41.582

7.  Mesenchymal Lineage Heterogeneity Underlies Nonredundant Functions of Pancreatic Cancer-Associated Fibroblasts.

Authors:  Erin J Helms; Mark W Berry; R Crystal Chaw; Christopher C DuFort; Duanchen Sun; M Kathrina Onate; Chet Oon; Sohinee Bhattacharyya; Hannah Sanford-Crane; Wesley Horton; Jennifer M Finan; Ariana Sattler; Rosemary Makar; David W Dawson; Zheng Xia; Sunil R Hingorani; Mara H Sherman
Journal:  Cancer Discov       Date:  2021-09-21       Impact factor: 38.272

8.  Regulator of calcineurin 1 gene isoform 4 in pancreatic ductal adenocarcinoma regulates the progression of tumor cells.

Authors:  Mengyi Lao; Xiaozhen Zhang; Tao Ma; Jian Xu; Hanshen Yang; Yi Duan; Honggang Ying; Xiaoyu Zhang; Chengxiang Guo; Junyu Qiu; Xueli Bai; Tingbo Liang
Journal:  Oncogene       Date:  2021-04-06       Impact factor: 9.867

Review 9.  Diversity and Biology of Cancer-Associated Fibroblasts.

Authors:  Giulia Biffi; David A Tuveson
Journal:  Physiol Rev       Date:  2020-05-28       Impact factor: 37.312

Review 10.  Dynamic Stromal Alterations Influence Tumor-Stroma Crosstalk to Promote Pancreatic Cancer and Treatment Resistance.

Authors:  Kendelle J Murphy; Cecilia R Chambers; David Herrmann; Paul Timpson; Brooke A Pereira
Journal:  Cancers (Basel)       Date:  2021-07-12       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.